"Expert IVUS-Eye" vs. IVUS-guided Left Main Bifurcation PCI
Recruiting now · Not applicable
Conditions studied: Coronary Artery Disease (CAD), Chronic Coronary Syndrome, Left Main Coronary Artery Disease, Coronary Bifurcation Lesion
In brief
This is a prospective, randomized, controlled trial comparing two strategies for optimizing stent implantation during bifurcation stenting of the left main coronary artery (LM): an intravascular ultrasound (IVUS)-guided approach versus a "IVUS-trained eye" approach based on angiographic assessment and operator experience. All patients receive the same stent brand and procedure steps to minimize variability. The primary objective is to compare the planimetric stent appearance between two strategies.
Key facts
- Study ID
- NCT07711106
- Run by
- Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
- People needed
- 50
- Starts
- 2026-07-01
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-07-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- De novo lesion in an unprotected left main coronary artery, indicated for bifurcational stenting (provisional or 2-stent)
- Patient referred for elective or delayed (non-emergency) stenting
- Technical feasibility of performing IVUS
- Signed informed consent
You may not qualify if…
- ST-elevation myocardial infarction (STEMI) within the preceding 72 hours
- Cardiogenic shock
- Isolated (non-bifurcation) left main lesion
- Prior PCI in the target segment
- Diameter of one of the left main main branches < 2 mm
- Occlusion in the proximal segment of one of the main left main branches without the possibility of simultaneous recanalization
- History of coronary artery bypass grafting (CABG)
- Severe comorbidity with expected life expectancy < 1 year
- Participation in another interventional study
- Patient is a woman who is pregnant or nursing;
- Female patient of childbearing potential, i.e. who are not surgically sterile or post-menopausal (defined as no menses for 2 years without an alternative cause);
- IVUS is strictly required for pre-PCI lesion severity assessment
- Patients unable to tolerate, obtain or comply with dual antiplatelet therapy for at least 6 months in stable patients and 1 year in ACS patients;
- Known contraindication or hypersensitivity to everolimus, platinum-chromium, or to anticoagulants.
Where it is running
- Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health — Saint Petersburg, Russia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.